A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer

Kamakshi Rao, Susan Goodin, Michael J. Levitt, Nisha Dave, Weichung J. Shih, Yong Lin, Terry Capanna, Susan Doyle-Lindrud, Parisa Juvidian, Robert S. DiPaola

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science